GSK3B and Alzheimer disease: Nine hits were identified in this screening, including inhibitors of well-known active kinases in AD, such as DLKi27 [94], indirubin-3′-monoxime [95] (GSK3β and CDK5 inhibitor), AZD0530 [96] (Fyn inhibitor), and demeclocycline HCl [97] (calpain inhibitor), along with luteolin [98,99] and curcumin [99] and its derivative J147 [100].